You just read:

Vtesse Announces Dosing of First Patient in Germany for Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease

News provided by

Vtesse, Inc.

05 Oct, 2016, 07:00 ET